Human cancers, including breast cancers, comprise clones differing in mutation content. Clones evolve dynamically in space and time following principles of Darwinian evolution 1, 2 , underpinning important emergent features such as drug resistance and metastasis [3] [4] [5] [6] [7] . Human breast cancer xenoengraftment is used as a means of capturing and studying tumour biology, and breast tumour xenografts are generally assumed to be reasonable models of the originating tumours [8] [9] [10] . However, the consequences and reproducibility of engraftment and propagation on the genomic clonal architecture of tumours have not been systematically examined at single-cell resolution. Here we show, using deep-genome and single-cell sequencing methods, the clonal dynamics of initial engraftment and subsequent serial propagation of primary and metastatic human breast cancers in immunodeficient mice. In all 15 cases examined, clonal selection on engraftment was observed in both primary and metastatic breast tumours, varying in degree from extreme selective engraftment of minor (,5% of starting population) clones to moderate, polyclonal engraftment. Furthermore, ongoing clonal dynamics during serial passaging is a feature of tumours experiencing modest initial selection. Through single-cell sequencing, we show that major mutation clusters estimated from tumour population sequencing relate predictably to the most abundant clonal genotypes, even in clonally complex and rapidly evolving cases. Finally, we show that similar clonal expansion patterns can emerge in independent grafts of the same starting tumour population, indicating that genomic aberrations can be reproducible determinants of evolutionary trajectories. Our results show that measurement of genomically defined clonal population dynamics will be highly informative for functional studies using patient-derived breast cancer xenoengraftment.
To evaluate xenograft clonal dynamics (see Supplementary Table 1 for definitions of terms used) we generated 30 xenograft lines by serially transplanting (up to 16 generations over 3 years) breast cancer tissue organoid suspensions from 55 patients (Extended Data Fig. 1 , Supplementary Table 2 and Supplementary Fig. 1 ) into highly immunodeficient NOD/SCID/Il2rg 2/2 (NSG) and NOD/Rag1
Il2rg 2/2 (NRG) mice 11 (details in the Supplementary Information). We carried out massively parallel whole-genome shotgun sequencing (WGSS) on DNA from xenograft passages of 15 patient lines (10 primary tumour-derived and five pleural effusion-derived), along with matched patient tumour and normal DNA (47 samples total, median sequencing depth 45.1, Supplementary Table 3 ). For these, plus 56 additional xenograft passage samples, we validated 3,187 somatic single nucleotide variant (SNV) positions (100-300 per tumour-xenograft series) and 132 structural variant positions by targeted-amplicon deep sequencing (Supplementary  Tables 4-6 ), quantifying allele ratios to a high level of precision. We surveyed the copy-number alteration (CNA) and loss of heterozygosity (LOH) landscapes using Affymetrix SNP Array 6.0 (Supplementary  Tables 7 and 8 ). The mutation load of somatic SNVs (range: 4.3-27.7 3 10 3 genome-wide; 57-1,040 in coding regions), CNA and LOH (34-67% of genome), and structural variants in the 15 tumour-xenograft series (Supplementary Figs 2 and 3 and Supplementary Table 9) were consistent with previous genome-wide breast cancer studies 4, [12] [13] [14] [15] [16] [17] , although low tumour cellularity hindered mutation discovery in case numbers SA429 and SA496 originating tumours. Tumour-xenograft pairs displayed comparable nucleotide substitution patterns ( Supplementary  Figs 2 and 4) , suggesting that mutational processes are maintained postengraftment.
To determine the extent of evolution in the SNV landscape, we first compared the genome-wide variant allele prevalences (the proportion of aligned reads at the SNV position with the variant base, see Supplementary Table 1 ) from WGSS data in xenograft relative to tumour (SA429 and SA496 excluded due to low tumour cellularity). As expected, sizeable proportions (range: 53.0-92.9%) of high-confidence SNVs are shared in tumour-xenograft pairs, with prevalences lying on a scatter plot diagonal indicating neutral dynamics (Extended Data Fig. 2a and Supplementary Figs 5a and 6) . Notably, all 15 samples also show clusters of SNVs prevalent in the xenograft while at or below the limit of detection in the tumour (range: 6.5-32.1% of SNVs, see for example, SA494, SA495 and SA499) and vice versa (range: 0.2-19.4%, see for example, SA494, SA495 and SA500), implying clonal selection on initial engraftment. Tumours and xenografts from SA494, SA495, SA499, SA500 and SA530 also exhibited substantial differences in structural variant content ( Supplementary Figs 3 and 7) .
To resolve clonal dynamics and genotypes, we applied a Bayesian clustering model (PyClone 4, 18 ) to SNV variant allele prevalences measured by targeted deep sequencing, accounting for the effect of copy number, LOH status and cellularity. SNVs with co-varying estimates of cellular prevalence (the proportion of tumour or xenograft cells bearing the mutation) across all time points are grouped into putative mutation clusters (Supplementary Table 1 ). Consistent with the raw variant allele prevalence measurements, several cases contained mutation clusters with high (75-100%) prevalences in the xenografts and low (0-15%) prevalences in the tumours, implying expansion of initially minor clones to dominate the xenograft (for example, clusters 3, 4, 3, 2, 8, 2 and 2 in  SA494, SA495, SA500, SA530, SA532, SA533 and SA535, respectively) (Extended Data Fig. 2b and Supplementary Fig. 5b ). Other series (SA493, SA499, SA501, SA531, SA534 and SA536) demonstrated non-neutral clonal dynamics but involving alleles occupying much smaller proportions of total cellular populations. Notably, polyclonal population structure specific to the xenograft was observed after initial expansion in SA493, SA494, SA495, SA500 and SA531, suggesting that initial selection on engraftment remains permissive to additional clonal evolution (Extended Data Fig. 2b and Supplementary Fig. 5b ). Polyclonal engraftment was evident in SA493, SA501, SA531 and SA532, suggesting that multiple clones maintained their fitness post-engraftment.
Analogously, we analysed clonal dynamics using CNAs as clonal marks, applying a probabilistic model (TITAN 19 ) that infers CNA and LOH from WGSS data, accounting for mixtures of tumour and normal cells and reporting estimates of mutation cellular prevalence and mutation cluster membership (Supplementary Table 10 ). Despite conservation of complex disruptions, such as chromothripsis in SA429 ( Supplementary  Fig. 8 ) and breakage-fusion-bridge cycles in SA429 and SA494 (Supplementary Figs 9 and 10), we identified substantial differences in copynumber architecture between tumour and xenograft in all cases (Extended Data Fig. 2c and Supplementary Fig. 5c ). These included a xenograftspecific deletion event containing TP53 (in SA500) that coincided with retention of a somatic SNV ( Supplementary Fig. 11 and Supplementary  Table 6 ). Notably, the predominant clonal dynamic (minor subclone expansion in SA494, SA495, SA532 and SA533; polyclonal engraftment in SA493 and SA501) mirrored those seen in SNV space.
We next asked how clonal dynamics differ after initial engraftment, using PyClone predictions over serial passage generations spanning up to 3 years (Extended Data Fig. 1 ). We distinguished statistically significant directional clonal dynamics by testing the overlap of 90% credible intervals derived from Bayesian posterior probability distributions (Fig. 1) . Cases showing strongest clonal dynamics in the first engraftment passages (for example, SA500, SA530, SA494 and SA535) exhibited more stable prevalence over subsequent passages. In contrast, cases showing moderate initial clonal dynamics showed more marked subsequent dynamics (for example, mutation clusters 2, 3 and 8 of SA501), in some cases leading to gradual expansion of a minor clone to dominate the xenograft over serial passages. We noted examples of all oestrogen receptor/ HER2 subtypes and primary/metastatic cancers evolving by these two different modes. Some mutation clusters showed non-dynamic patterns over time (for example, clusters 1, 4 and 6 of SA500, clusters 1-3, 5, 7, 9 and 10 in SA532, as well as the highest prevalence clusters representing putative ancestral mutations that remained invariant, as expected). For two cases we noted preferential engraftment of initial transplants in mammary fat pad over subrenal sites (SA496 4 of 4 mammary fat pad versus 0 of 4 subrenal; SA429 2 of 4 mammary fat pad versus 0 of 4 subrenal, Extended Data Fig. 1 ). However, transplant site changes in established xenografts were not associated with unusually strong clonal dynamics ( Fig. 1 , see SA495 X3-4, SA499 X3-4, SA429 X1-2 and SA496 X1-2, where X denotes the xenograft passage).
To validate the population-based inference of mutation clusters and clonal genotypes directly, we carried out single-cell analyses of cases SA494 (an example of extreme initial selection) and SA501 (complex post-engraftment clonal dynamics). We performed multiplexed targeted Cluster (n) 1 (68) 2 (22) 3 (12) 4 (9) 5 (7) 6 (4) 7 (4) 8 ( (14) 3 (14) 4 (5) 5 (5) 6 ( 1 (60) 2 (23) 3 (15) 4 (14) 5 (13) 6 (11) 7 (9) 8 (6) 9 (5) 10 (5) 11 (3) 12 (3) 13 (2) 14 ( 
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re-sequencing of SNVs in 210 isolated tumour and xenograft nuclei, using microfluidic devices. We determined evolutionary relationships between nuclei by Bayesian phylogenetic inference 20 , deriving consensus genotypes for clades representing high probability branch points in the phylogenetic tree.
As predicted by PyClone, two major clades emerge in the SA494 phylogeny, comprising tumour and xenograft nuclei respectively, bearing mutually exclusive sets of alleles in addition to a set of shared alleles (Extended Data Fig. 3a-c and Supplementary Fig. 13 ). The ancestral clone SNVs (PyClone cluster 1) are common to nuclei from both clades, while SNVs in the predicted dominant tumour clone (cluster 2) and minor engrafting clone (cluster 3) are restricted to tumour and xenograft nuclei, respectively (Extended Data Fig. 3d, genotypes A and B) . This confirms the ancestral relationship between tumour and xenograft, verifies the expansion of a very minor clone (,5%), while also showing unambiguously that mutation clusters inferred by PyClone represent major clonal genotypes.
PyClone analysis of SA501 ( Fig. 2 and Supplementary Fig. 12 ) revealed a dynamic and complex clonal architecture, with gradual expansion of minor mutation clusters observed over consecutive passages, and expansion followed by decline of other clusters (Fig. 2d) . The major mutation clusters and their gradual change in prevalence over time Cluster (n) 1 (60) 2 (23) 3 (15) 4 (14) 5 (13) 6 (11) 7 (9) 8 (6) 9 (5) 10 (5) 11 (3) 12 (3) 13 (2) 14 ( 
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predicted by PyClone were confirmed by the clonal genotypes of single cells from SA501 passages X1, X2 and X4 ( Fig. 2b and Supplementary  Fig. 13 ). Phylogenetic inference resolved the clonal genotypes of five major clades (Fig. 2a, e) , with cascading acquisition of mutations from parental to descendant clone (Fig. 2c) . Genotypes A and B belong to sibling clades defined by the addition of cluster 5 and cluster 4 mutations, respectively, to the ancestral genotype defined by clusters 1 and 8; genotype C was derived from genotype B with the addition of mutations in cluster 7; genotype D derived from genotype C with the addition of mutations defined by cluster 2; and genotype E derived from genotype D with the addition of cluster 3 mutations and loss of cluster 8 mutations (Fig. 2a, c, e) . The clonal dynamics measured in the population was reflected in the relative abundance of single-cell genotypes in each xenograft (Fig. 2f) , mirroring bulk population predictions (Fig. 2d) . Both X1-and X2-sampled nuclei show an admixture of clones defined by genotypes A, B, C and D (relatively rare in X1). Genotype E is confined exclusively to X4 nuclei, suggesting that by passage 4, this clone had nearly exhaustively outcompeted its ancestor and sibling clones. Its eventual dominance is mirrored by the decline of genotype A (initially present in X1 and X2), suggesting that the descendants of genotype B outcompeted those of genotype A over time.
Taken together, these single-cell genotyping experiments combined with phylogenetic inference have recapitulated population-level PyClone predictions in a simple (SA494) and a complex (SA501) clonal expansion model. Thus, single-cell genotyping validates PyClone mutation clusters as genomic markers of major clonal genotypes, while providing additional insight into the ancestral lineages of cell populations.
Finally, to determine whether directional clonal dynamics might be associated with deterministic as opposed to stochastic processes (such as random genetic drift), we tested whether similar clonal dynamics occurred when the same tumour population was multiply transplanted into different mice. In 4 of 5 series examined, parallel clonal dynamics of the same mutation cluster(s) were observed (arrows in Fig. 3a, b and Extended Data Fig. 4a , b: SA501 2 of 2 replicate mice at passage X3 and 4 of 4 at X4; SA535 3 of 3 at X1; SA532 3 of 3 at X1, 3 of 7 at X2 and 2 of 2 at X3; SA429 3 of 5 at X2). These include reproducible expansions of initially minor subclones, implying a high likelihood of a shared deterministic mechanism rather than repeated rare stochastic events (for example, arising from transplants close to limiting dilution). In SA501 the same pattern (expansion of cluster 3 mutations mirrored by a decline of cluster 5 mutations) was independently observed in transplants at passage 2, 3 and 4 (2B, 3B and 4A-D in Fig. 3a) , suggesting shared clonal fitness but variable timing. We also observed instances of divergence, for example expansion of SA532 cluster 4 specific to branch 1A-2A-3A-4A (Extended Data Fig. 4a ). SA535 (Fig. 3b) and SA532 showed examples of clonal expansion patterns replicated in related but different immunodeficient mouse strains (NSG, NRG). To control against shared clonal structure imposed through joint inference of the data sets, we also carried out independent PyClone analyses that excluded all but one transplant at each passage, and observed high correlations of inferred mutation prevalences between same-passage replicates (Extended Data Fig. 5 ; median Pearson correlations 0.94, 0.93, 0.91, 0.91 and 0.46 for SA501, SA535, SA532, SA429 and SA496, respectively). These data indicate that clonal genotypes defined by somatic aberrations (and/or closely co-segregating genomic factors) can be biologically meaningful determinants of fitness, leading to consistent and reproducible clonal dynamics.
We show here that patient-derived xenograft clonal dynamics on initial transplant vary from polyclonal engraftment with only moderate clonal selection, in which tumour and xenograft clonal prevalence are broadly similar (a minority of cases), to highly skewed dynamics in which initially minor prevalence clones expand to dominate the xenograft (the majority of cases). Expansion of minor subclones has been suggested in previous xenotransplantation studies using malignant epithelial 10, [21] [22] [23] or haematopoietic 24, 25 cells, without formal resolution of the clonal genotypes or pattern of subsequent clonal dynamics. In contrast with preliminary studies of xenoengraftment, we find correlated dynamics of clones defined by SNVs or copy-number aberrations as clonal marks. Expansion patterns are most often pronounced in the initial establishment passage; however, in cases where initial clonal selection is weak, subsequent evolution over passaging is more evident. Furthermore, polyclonal sub-structure may emerge even in xenografts that have undergone a modest population bottleneck on initial engraftment. These dynamic processes are not evident from histopathological or imaging characteristics, which remain broadly stable, consistent with previous reports 8, 9, 23 . Notably, we find that the population dynamics of genomically defined clones are replicated when transplants are carried out in multiple mice, implying that the basis of selection is non-random and probably closely linked to the particular mutation genotype (or epigenotype) that defines the clone. The most parsimonious explanation for repeated observation of these clonal dynamics is that the clones are mostly pre-existing, and variations in clonal fitness explain the dynamic behaviour, as opposed to de novo somatic mutation. Furthermore, cases in which conversion from minor to dominant clone occurs monotonically over multiple passages demonstrate that selective fitness can be persistent rather than transient. Thus, specific somatic genotypes are likely to act as genetic markers of clonal growth and fitness advantages, yielding predictable and reproducible clonal dynamics. Determination of the precise aberrations that give rise to selective clonal fitness still faces considerable challenges. In this regard, we believe that ascertainment of clonal dynamics will prove essential for fully informed future studies of drug response and tumour biology in xenografts of human breast cancers. (23) 3 (15) 4 (14) 5 (13) 6 (11) 7 (9) 8 (6) 9 (5) 10 (5) 11 (3) 12 (3) 13 (2) 14 ( Cluster (n) 1 (60) 2 (23) 3 (15) 4 (14) 5 (13) 6 (11) 7 (9) 8 (6) 9 (5) 10 (5) 11 (3) 12 (3) 13 (2) 14 (2) 15 (1) 16 (1) 17 (1) 18 (1) 19 ( Cluster (n) 1 (85) 2 (15) 3 (9) 4 (6) 5 (6) 6 (5) 7 (4) 8 (2) 9 (2) 10 (2) 11 ( Cluster (n) 1 (66) 2 (12) 3 (10) 4 (8) 5 (5) 6 (3) 7 ( Cluster (n) 1 (93) 2 (27) 3 (12) 4 (7) 5 (7) 6 ( LETTER RESEARCH
